Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
23.09
-1.27 (-5.21%)
Nov 3, 2025, 10:17 AM EST - Market open
Liquidia Market Cap
Liquidia has a market cap or net worth of $1.99 billion as of November 3, 2025. Its market cap has increased by 102.57% in one year.
Market Cap
1.99B
Enterprise Value
2.14B
1-Year Change
102.57%
Ranking
Category
Stock Price
$23.09
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $1.99B, an increase of 1,084.84%. That is a compound annual growth rate of 40.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 2.10B | 110.70% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | 127.84M | 60.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |